Open AccessNonalcoholic Fatty Liver Disease and Obesity Treatment
Author(s) -
Katherine T. Brunner,
Cameron J. Henneberg,
Robert M. Wilechansky,
Michelle T. Long
Publication year - 2019
Publication title -
current obesity reports
Language(s) - English
Resource type - Journals
ISSN - 2162-4968
DOI - 10.1007/s13679-019-00345-1
Subject(s) - nonalcoholic fatty liver disease , medicine , pioglitazone , insulin resistance , weight loss , fibrosis , type 2 diabetes , fatty liver , liver biopsy , diabetes mellitus , gastroenterology , endocrinology , obesity , disease , biopsy
Nonalcoholic fatty liver disease (NAFLD), the most prevalent cause of chronic liver disease worldwide, is strongly associated with obesity and insulin resistance.